Medicines Moleculin Receives Approval from the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) for Protocol Amendment to Phase 1a Clinical Trial of WP1122 for the Treatment of COVID-19 By Helena Musk / May 11, 2022
Medicines Doctors and treatment threatened after Alabama outlaws gender-affirming medicines for trans kids By Helena Musk / May 10, 2022
Medicines FDA Grants Regenerative Medicine Advanced Therapy (RMAT) designation to Autolus’ CAR T cell therapy, obe-cel, for the treatment of adult B-ALL By Helena Musk / April 27, 2022
Medicines Loki Therapeutics Announces Publication in Science Translational Medicine Demonstrating Potential of AWAKE-LM-TT as a Treatment for Pancreatic Cancer By Helena Musk / March 28, 2022